Thus further evaluation of STACs activity in a cancer-specific manner is required. For example, in a mouse model of T2D, NMN supplementation mitigates negative metabolic effectsinsulin insensitivity, glucose intolerance, and inflammationof age-related or diet-induced diabetes, potentially due to the activation of SIRT1 and other sirtuins, and their downstream target pathways (Yoshino et al., 2011). For example, which RSV effects occur through SIRT1, and which are due to effects on other targets? Therefore the combination of PARP inhibitors and sirtuin inhibitors represents a potentially interesting therapeutic strategy to treat cancer. Sirtuin-activating compounds (STACs) including plant-derived metabolites and the well-known resveratrol, represent the first and most potent sirtuin activator and have been shown to extend life span in various organisms (Hubbard and Sinclair, 2014; Pearson et al., 2008). By continuing you agree to the use of cookies. These STACs activate SIRTs allosterically [235]. (C) Crystal structure of Sirt1 in complex with FdL peptide (beige) and three resveratrol molecules (cyan) around its fluorophore (PDB entry 4BTR). HDACs also play a major role in pancreatic beta cell differentiation, preservation, and proliferation, as well as improving insulin resistance and inhibiting adipogenesis [102]. NAD+ bioavailability is reduced in disease states and aging.89 A precursor of NAD+, nicotinamide, is being evaluated as a therapy to correct NAD+ deficiency and improve sirtuin activity. It will also be critical to assess how PARP inhibitors affect the activity of the other sirtuins. Interestingly, the compounds show no effects against Sirt1, 2, and 3, as expected from the Sirt6-specific binding site, but stimulate Sirt5s desuccinylase activity.36 The molecular basis of this Sirt5 effect remains to be characterized, but it shows that the Sirt6 activators and the structures of Sirt6/activator complexes will now have to be exploited for further development to obtain highly specific Sirt6 modulators. In this regard, a specific amino acid in SIRT1 required for STAC-mediated activation has recently been identified. 6.1). SRT1720 has been shown to reduce cancer cell viability and sensitize cancer cells to chemotherapy drugs. Moreover, vorinostat (THS-785 and ITF2357) has been shown to diminish IL-1b expression and to prevent -cell loss in diabetic settings [100,101]. NAD+ bioavailability is reduced in disease states and aging.65 A precursor of NAD+, nicotinamide, is paving ways as a therapy to correct NAD+ deficiency. The mechanism by which STACs activate SIRTs remains controversial. AMPK may then activate sirtuin 1 indirectly by elevating intracellular levels of its cosubstrate NAD+ (Canto et al., 2009). A considerable amount of data has accumulated on treating humans with potential STACs with inconclusive results [9093]. -cell destruction found in diabetic pancreatic islets, caused by hyperacetylation of the proinflammatory NF-B promoter gene, can be counteracted by HATi, as garcinol [99]. Application of an mTOR inhibitor, rapamycin, has been shown to act as a rejuvenating therapy, even when applied late in life.66, Our previous studies have implicated a selenorganic peroxynitrite scavenger, ebselen, in in vitro and in vivo rejuvenation of EPC39 and have been reviewed elsewhere.12,67, Sbastien Moniot, Clemens Steegborn, in Introductory Review on Sirtuins in Biology, Aging, and Disease, 2018, Sirtuins show beneficial effects on lifespan and healthspan. The in vivo study of MDL-800 in a HCC tumor xenograft model and in SIRT6 KO mice also demonstrated a significant impediment of tumor growth by activating the deacetylase activity of SIRT6 [288]. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransfereases (NMNATs). RSV has been found in many plants, such as cranberries, grapes, peanuts, and Japanese giant knotweed [271]. L. Raffaghello, V. Longo, in International Review of Cell and Molecular Biology, 2017. SRT2104 has shown benefit in psoriasis [261] and metabolic syndrome [262]. Based on the earlier studies of sirtuin 1 and its activation by resveratrol, a number of small molecule SIRT1 activators have been synthesized and are currently being tested.63 Sirtuin-activating compounds (STACs) exert their effect by allosteric activation of this deacetylase. In comparison, these drugs were poorly active in healthy PBMCs [52]. Crystal structures of Sirt6/activator complexes revealed that the pyrrolo[1,2-a]quinoxalines bind to the acyl channel exit (Fig. Consistent with the observed binding mode, the compounds activate Sirt6 only against acetylated substrate and instead show competition against substrate carrying the longer myristoyl modification that requires these Sirt6 regions for binding, indicating the exciting possibility to develop acyl-specific Sirt6 modulators. Similarly, primary leukemia cells, leukemia cell lines, healthy leukocytes, and hematopoietic progenitors were treated with sirtuin inhibitors (sirtinol, cambinol, and EX527) in combination with HDAC inhibitors (valproic acid, sodium butyrate, and vorinostat). A first meta-analysis of six studies regarding resveratrol supplementation showed statistically significant positive effects on systolic BP, hemoglobin A1c, creatinine, but not on fasting glucose, homeostatic model assessment of insulin resistance, diastolic BP, or lipid profiles [90]. Furthermore, another study also reported an enhanced effect when SRT1720 was used in combination with dexamethasone or bortezomib [269,283]. However, clinical trials to date have been less promising than the preclinical studies. Treatment of lymphoma cell lines and a lymphoma cell line xenograft in mice with cambinol (a SIRT1 inhibitor) causes apoptosis [53]. RSV regulates SIRT1 through the AMP-dependent kinase (AMPK) pathway which activates SIRT1 by increasing the intracellular concentration of NAD+ [273,276]. Moreover, in rhesus monkeys, under a high-fat and high-sugar diet, resveratrol exerts antiinflammatory effects in visceral white adipose tissue (Jimenez-Gomez et al., 2013). Despite SIRT1 being the most studied SIRT and possessing a wide range of activators and inhibitors, SIRT1 still yields controversial results regarding whether or not its activation or inhibition can produce an anticancer effect [273275]. Clinical trials aimed at increasing the intake of this polyamine seems feasible for the purpose of suppressing cardiovascular aging in humans. Another venue for rejuvenation therapy is based on the series of findings implicating mTOR activation and the resulting defect in autophagy in senescence. Thus, spermidine is a promising CR mimetic and has the potential to be safe for testing the epigenomic-dependent and independent effects on human healthy lifespan. reported that MDL-800 increases the deacetylase activity of SIRT6 by up to 22-fold via binding to an allosteric site. 5.2C), leading to a closed conformation and enabling the same activator/FdL fluorophore interactions previously observed in the Sirt5/FdL/resveratrol complex (Fig. Promising CR mimetics with properties of cardiovascular protection include compounds that intersect with the critical signaling pathways identified above. Epigenetic modifications, unlike genetic changes, are usually reversible. It will be interesting to see how newer, more potent, and more orally bioavailable sirtuin modulators evolve. The promising results in preclinical models led the clinicians to test resveratrol in humans where it exerts beneficial effects on elderly and obese subjects (Timmers et al., 2011). Ken Shinmura, in Nutritional Epigenomics, 2019. 5.2A).32,33 The flexibility of the linker between SBD and catalytic core and of a salt bridge between Glu230 and Arg446 that can form in this closed Sirt1 conformation were indeed essential for Sirt1 activation also with regular substrates.30 Thus, resveratrol and synthetic STACs are assumed to activate Sirt1 against artificial as well as natural substrates through binding to the SBD and formation of the closed conformation, resulting in direct activator/substrate contacts that increase substrate affinity and rationalize the relevance of the substrate sequence for activation (see above). The mechanism underlying the beneficial effects of resveratrol is controversial since it has been proposed that the direct activation of sirtuin 1 by resveratrol is an in vitro artifact (Beher et al., 2009; Kaeberlein et al., 2005; Pacholec et al., 2010) and that resveratrol works primarily by activating AMPK (Canto et al., 2009), potentially by inhibition of phosphodiesterases (PDE). A variety of stilbene derivatives with modifications at the 4 position of the B ring of resveratrol were synthesized that have lower toxicity and higher potency with respect to SIRT1 activation and lifespan extension in budding yeast, showing for the first time that it is possible to improve upon naturally occurring STACs.3. Figure 5.2. UBCS039 is a newly synthesized pyrrolo[1,2-a]quinoxaline derivative, the first synthetic SIRT6 activator [286]. The more commonly known synthetic STACs which are commercially available and reported to target cancer include SRT1720, SRT3025, SRT1460, SRT2183, and UBCS039 [235,267270]. Administration of spermidine to aged yeasts reversed hyperacetylation of histone H3 and activated gene programs associated with autophagy and cell stress resistance, resulting in longevity. Modulating sirtuin activities could also be an area of prevention of hematologic malignancies. An interesting question is how much of the carcinogenic effect of these exposures is conferred by the theoretical reduced sirtuin activity. William Giblin, David B. Lombard, in Handbook of the Biology of Aging (Eighth Edition), 2016. sarcomas, lymphomas, teratomas, and carcinomas) exhibited SIRT1 activation after treatment with RSV, which in turns effectively inhibited the tumorigenesis of SIRT1+/; p53+/ mice [60]. PARPs are another major utilizer of NAD+ in humans. This section will summarize preclinical and clinical studies of sirtuin modulators and discuss some of the most impactful future avenues of investigation. RSV treatment in high-proliferative SIRT1 knockdown prostate cancer cells have a reverse effect by inhibiting cancer cells growth and proliferation [277]. Further, searching for predictive biomarkers for sensitivity to sirtuin modulators will be a critical next step. Among these epigenetic modifiers, valproic acid, sodium phenylbutyrate, vorinostat, givinostat, and curcumin are HDACi; resveratrol is a STACs; AMI-1 is a PRMTis; tranylcypromine is part of HDMis; and hydralazine, procainamide, RG108, and MG98 belong to DNMTis [98]. Figure 3.6. However, this combination could have significant toxicity, as it would presumably prevent healthy cells from responding to damage and stresses induced by chemotherapy. (A) Targets of NAD-boosting molecules or NBMs. NAD+ is synthesized de novo from tryptophan via a series of enzymatic reactions, including the initial conversion of tryptophan to kynurenine by the enzyme indoleamine 2,3-dioxygenase (IDO). Furthermore, resveratrol provides positive effects for systolic blood pressure, hemoglobin A1c, and creatinine in patients affected by type 2 diabetes (Hausenblas et al., 2015). . Resveratrol effects on Sirt5 and on Sirt3, which can be inhibited by this compound, are weak and likely not relevant for resveratrols in vivo effects, in contrast to Sirt1 activation, which appears essential for several physiological resveratrol effects.26,29 However, resveratrol potency against Sirt1 is also moderate, and its effects on other targets and limited bioavailability render it less suited as a pharmacological Sirt1 activator.28 Tests with resveratrol derivatives identified, e.g., similar effects for the more soluble piceatannol, and 4-bromo-resveratrol as a potent Sirt1/3 inhibitor, but no significantly improved sirtuin activators.21,32 Thus, compound screens were employed for the identification of unrelated Sirt1 activators and yielded a variety of potent substances. STACs have been reported to interact with a specific region on the SIRT1 protein (Hubbard et al., 2013). Bone marrow transplant (BMT) is a treatment often employed in hematologic malignancies. (A) STACs resveratrol and SRT1720; (B) NAD+ precursors nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN); (C) Potential nicotinamide phosphoribosyltransferase (NAMPT) activator P7C3 and CD38 inhibitor apigenin. Further investigation will need to discern the nature of their seemingly contradictory oncogenic and tumor-suppressive functions. As this chapter has discussed, many sirtuins have been shown to promote chemotherapy resistance. A sustained activation of SIRT6 as a result of UBCS039 treatment also resulted in autophagy-related cell death [287]. Resveratrol and newly developed analogues should have a place in the prevention of endothelial cell senescence and the restoration of metabolic abnormalities. Despite the apparent beneficial effects of RSV and other STACs in multiple systems, in human patients with nonalcoholic fatty liver disease, RSV treatment appeared to exert toxic effects on hepatocytes, and did not ameliorate liver steatosis or insulin resistance (Chachay et al., 2014). In the context of CD38-deficient mice, protection against weight gain was lost when animals were treated with a sirtuin inhibitor, implicating sirtuin activation in this effect. The sirtuins represent an intriguing therapeutic target in hematologic malignancies. In cancer, resveratrol for 45 weeks reduces prostate cancers by about 50% in mice [260]. In this way, STACs bind to an allosteric site of SIRT1 and increase the enzymes affinity for target substrates.6 Extensive research has identified the specific amino acid residues of the STAC binding domain and determined that they activate SIRT1 via a bend-at-the-elbow model in which the binding of an STAC exposes the substrate binding site of SIRT1.6. ScienceDirect is a registered trademark of Elsevier B.V. ScienceDirect is a registered trademark of Elsevier B.V. Complementary and Alternative Therapies and the Aging Population, Pharmacological Approaches for Modulating Sirtuins, Introductory Review on Sirtuins in Biology, Aging, and Disease, The bifunctional roles of sirtuins and their therapeutic potential in cancer, Sirtuin Biology in Cancer and Metabolic Disease, Sirtuins, Healthspan, and Longevity in Mammals, Handbook of the Biology of Aging (Eighth Edition), High-throughput screens have been conducted to identify small molecule, Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010; Park et al., 2012, Barger et al., 2008a,b; Pearson et al., 2008, Miller et al., 2011; Pearson et al., 2008, Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010, Metabolic Alterations at the Crossroad of Aging and Oncogenesis, International Review of Cell and Molecular Biology. Despite substantial recent progress (reviewed in Hubbard and Sinclair, 2014), many key questions remain in this area. The activation of SIRT6 by MDL-800 inhibits cell proliferation and induces cell cycle arrest in HCC. Among various candidates for CR mimetics, Epigenetics in Human Disease (Second Edition), . This study places SIRT1 upstream of AMPK activation and proposes a model of sustained sirtuin activation via RSV treatment that results in a net accumulation of NAD+. Interestingly, there is evidence that modulating sirtuin activity could help prevent graft versus host disease (GVHD), one of the major and devastating complications associated with BMT. Wang and colleagues have previously shown that in vivo SIRT1+/; p53+/ mice xenograft models with different malignancy types (i.e. Sirtuin inhibitors synergized with HDAC inhibitors to kill leukemia cells, but this was not the case in healthy leukocytes and hematopoietic progenitors [52]. The role of sirtuins in transplant biology is a fascinating area worthy of future investigation. Activator development for the other isoforms, which lack Sirt1s SBD, has lagged behind, but promising compounds are now emerging. Going through each of the seven sirtuins above, I have tried to highlight potential therapeutic opportunities. An increase in the cellular NAD+/NADH ratio will increase sirtuin activity. The sirtuin inhibitors tenovin-1 and tenovin-6 show activity in models of a number of hematologic malignancies, including ALL [37], DLBCL [257], and cutaneous T cell lymphoma [45]. There are two different types of STACs: natural and synthetic. In vitro data using these compounds in models of hematologic malignancies show promise. Reduced NAD+ levels induced by advanced age, caloric excess, or a sedentary lifestyle would impair activity of sirtuins and other NAD+-dependent cellular processes. The drugs which have been developed to target and activate SIRTs are mainly focused on antiaging, antiinflammatory, antidiabetic, and antiobesity activity. It will be interesting to see how these affect sirtuin signaling in hematologic malignancies. In addition, calorie restriction diet, which possibly induces SIRT1, acts via mTOR signaling and nicotine amide dinucleotide (NAD)-dependent pathways,64 both representing novel venues of rejuvenation therapy. NaMN is converted to nicotinic acid adenine dinucleotide (NAAD) by NMNATs, and then NAAD to NAD+ by NAD-synthase. Non-allosteric methods to activate sirtuins have also received intense scrutiny as an alternative to STACs. A number of clinical trials involving resveratrol showed benefits in glucose metabolism and cardiovascular disease risk factors [263,264], but many others have shown little to no benefits [265]. Copyright 2022 Elsevier B.V. or its licensors or contributors. 1,4-Dihydropyridine (DHP)-based compounds, e.g., which can activate Sirt1 against regular substrates, showed activating effects on Sirt2 and Sirt3 in the FdL assay, but such effects remain to be confirmed with physiological substrates.34 The isoform besides Sirt1 for which potent activation against physiological substrates is well established is Sirt6. The use of CR mimetics would be much easier to incorporate into clinical practice than lifelong CR [4]. The efficacy of resveratrol is limited by its poor bioavailability and low potency. SIRT1 deficiency induced an abnormal accumulation of cells in the early phases of mitosis-impaired DNA damage repair, and chromosome instability which could subsequently cause cancer [60]. In addition, resveratrol delays the onset of neurodegeneration and improves learning and memory in aged mice (Graff et al., 2013; Zhao et al., 2013). Moreover, such studies might suggest ways to modulate sirtuin signaling to enhance treatment efficacy. SIRT1 activators and inhibitors have been through the first clinical trials with evidence of safety and some efficacy. Cells bearing a SIRT1 mutant at this site do not show the increased mitochondrial copy number and ATP content normally induced by STAC treatment (Hubbard et al., 2013). HDACi can also improve insulin signaling through trichostatin, which increases glucose transporter GLUT4 content and its translocation in muscle cells, lung, liver, kidney, and preadipocytes, providing long-term elevation of GLUT4 in insulin target tissues [105,106]. Alternatively, synthetic STACs such as SRT2170 and SIRT1460 have been synthesized to overcome the RSV limitation. NAD+ is broken down by CD38, poly ADP-ribose polymerase 1 (PARP1), and sterile alpha and TIR motif containing protein 1 (SARM1). This was also seen with pharmacologic PARP inhibition in vitro and in vivo [269]. This suggests a potential therapeutic strategy in treating leukemia with a combination of sirtuin and HDAC inhibitors [52]. Activation of Sirt6-dependent deacetylation can be achieved with fatty acids, and competition experiments implicated the enzymes long acyl-binding channel as a binding site.35 This activating effect required several hundred M fatty acid concentrations, however, and only more recently, pyrrolo[1,2-a]quinoxaline-derived compounds were discovered as first potent Sirt6 activators.36 These compounds increase Sirt6-dependent deacetylation of peptide substrates, histone proteins, and complete nucleosomes. In mice and nonhuman primates fed a high-fat diet, resveratrol protects against the effects of obesity and age-related metabolic decline, increases insulin sensitivity and mitochondrial functions, and prevents liver steatosis (Baur et al., 2006; Fiori et al., 2013; Jimenez-Gomez et al., 2013). Resveratrol also shows benefit in improving insulin sensitivity in nonhuman primates [259]. The different classes of synthetic STACs consist of imidazothiazoles, oxazolopyridine, thiazolopyridines, benzimidazoles, and bridged ureas [235,263]. Concordantly, Parp knockout mice show increased SIRT1 activity, mitochondrial metabolism, and biomass [269]. Thus, targeting epigenetic modifications, especially HDAC, could delay the progression of a hyperglycemic state and the onset of diabetic complications. These compounds are presently undergoing clinical trials. Huang et al. Using public database resources, Soda etal. Thus, human clinical studies using NAD+ precursors are currently ongoing. These compounds include biguanides such as metformin, which targets the AMPK and insulin signaling pathways; resveratrol, which partially affects sirtuin activity; and rapamycin, which interacts with mTOR signaling. Furthermore, spermidine retarded cardiac aging via enhanced autophagy, preserved mitochondrial function, anti-inflammatory properties, and prevented stem cell senescence [99]. Another strategy to modulate sirtuin activity in hematologic malignancies is by inhibiting endogenous breakdown of NAD+. Interestingly, SRT1720 improves insulin sensitivity, lowers plasma glucose, and increases mitochondrial capacity in experimental diabetes models, thus representing a promising new therapeutic approach for treating age-related diseases such as type 2 diabetes (Milne et al., 2007). Means of sirtuin activation. NBMs supply precursors for NAD+ synthesis. Synthetic activators such as SRT1720 and SRT2104 improve the metabolic profile and extend life span and health span of mice under a high-fat and normal diet (Mitchell et al., 2014; Minor et al., 2011).